Engineering amyloidogenicity towards the development of nanofibrillar materials
Related Experiment Video
Updated: Aug 29, 2026

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
Published on: July 6, 2019
Daizo Hamada1, Itaru Yanagihara, Kouhei Tsumoto
1Department of Developmental Infectious Diseases, Research Institute, Osaka Medical Centre for Maternal and Child Health (MCHRI), 840 Murodo-cho, Izumi, 594-1011, Osaka, Japan. daizo@lab.mch.pref.osaka.jp
Abstract:
When folded into their native structures, proteins in biological systems function as nanostructured machines. By contrast, some polypeptides tend to aggregate into other well-ordered structures, namely amyloid fibrils. Such well-ordered protein fibrils are attractive materials for nanobiotechnology because they self-associate through noncovalent bonds under controlled conditions - a property that is shared with small organic molecules called organogelators. Recently, the use of amyloid fibrils as structural templates for constructing nanowires has been demonstrated. Such applications will potentially become one of the next trends in protein engineering and nanobiotechnology.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology

